About US
Contact us
-
The Top 10 Drug Advertising SpendsWhile the grand party in direct-to-consumer (DTC) advertising may have peaked about 5 years ago, it remains an important method of marketing drugs. The industry last year spent $2.4 billion on televis2012/8/10
-
India's Strides may put its Agila injectables unit on the blockBy Tracy Staton Shopping for an Indian drugmaker? Strides Arcolab may have a deal for you. As Bloomberg reports, Strides is apparently considering the sale of its injectables unit, Agila Specialt2012/8/10
-
Bristol-Myers Squibb executive charged with insider tradingA Bristol-Myers Squibb executive has been charged for insider trading by the Securities and Exchange Commission (SEC) in the US.The SEC alleges that Robert D Ramnarine made over $300,000 in illegal pr2012/8/9
-
Pfizer fined and Teva investigated as part of major bribery crackdownPfizer has been fined $60m by the US Securities and Exchange Commision for the bribery of foreign health officials and doctors in Eastern Europe, Asia and the Middle East, as part of a crackdown on th2012/8/9
-
DoJ hasn't given up on prosecuting execs for pharma misdoingsBy Tracy Staton Billions are rolling into the Justice Department off Big Pharma's fraud settlements. The recent GlaxoSmithKline ($GSK) deal, at $3 billion, broke Pfizer's ($PFE) previous record,2012/8/8
-
Top 11 Fastest-Growing Generics CompaniesBy Tracy Staton and Nesa Nourmohammadi For generics makers, Big Pharma's patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs c2012/8/8
-
J&J acknowledges what everyone knows, it settled with DoJBuried deep in Thursday's quarterly report filing is Johnson & Johnson's ($JNJ) acknowledgement that it has an agreement to settle criminal cases brought by the Department of Justice and some stat2012/8/6
-
Generic savings tell a different patent-loss taleEarnings season has provided one measure of how hard patent losses and generic competition have hit pharma companies. The thousands and thousands of laid off workers is another gauge. But a new IMS st2012/8/6
-
SFDA issues the Second Summary of Announcements of Illegal Drug, Medical Device, and Health Food Advertisements in 2012On July 20, 2012, the State Food and Drug Administration (SFDA) issued the Second Summary of Announcements of Illegal Drug, Medical Device, and Health Food Advertisements in 2012.2012/8/3
-
2012’PhexTour pharmaceutical excipients application technology national tour seminar ——the sixth Harbin station has come to an end2012 PhexTour pharmaceutical excipients application technology national tour seminar the sixth station-Harbin, on July 27th, in Harbin Weiye hotel has come to an end. Nearly 20 local pharmaceutical2012/8/3